3 TSX Penny Stocks With Over CA$8M Market Cap

The Canadian market has shown strong momentum as it heads into 2025, supported by resilient consumer spending and rising corporate profits, although potential curveballs remain a consideration for investors. Amidst this backdrop, penny stocks—often seen as relics of past market eras—continue to hold relevance for those seeking affordable entry points with growth potential. These smaller or newer companies can offer surprising value when backed by solid financial foundations, presenting opportunities worth exploring in the current economic climate.

Top 10 Penny Stocks In Canada

Name	Share Price	Market Cap	Financial Health Rating
Alvopetro Energy (TSXV:ALV)	CA$4.36	CA$154.9M	★★★★★★
Amerigo Resources (TSX:ARG)	CA$1.73	CA$283.52M	★★★★★☆
Pulse Seismic (TSX:PSD)	CA$2.37	CA$120.08M	★★★★★★
PetroTal (TSX:TAL)	CA$0.65	CA$574.88M	★★★★★★
Mandalay Resources (TSX:MND)	CA$3.66	CA$324.12M	★★★★★★
Vox Royalty (TSX:VOXR)	CA$3.76	CA$187.19M	★★★★★★
Findev (TSXV:FDI)	CA$0.45	CA$13.03M	★★★★★☆
Foraco International (TSX:FAR)	CA$2.15	CA$212.76M	★★★★★☆
NamSys (TSXV:CTZ)	CA$1.10	CA$30.89M	★★★★★★
East West Petroleum (TSXV:EW)	CA$0.04	CA$3.62M	★★★★★★

Click here to see the full list of 959 stocks from our TSX Penny Stocks screener.

Let's uncover some gems from our specialized screener.

Captiva Verde Wellness (CNSX:PWR)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Captiva Verde Wellness Corp. is a real estate company that invests in sports and wellness opportunities, with a market cap of CA$8.95 million.

Operations: Captiva Verde Wellness Corp. has not reported any specific revenue segments.

Market Cap: CA$8.95M

Captiva Verde Wellness Corp., with a market cap of CA$8.95 million, is pre-revenue, making it a speculative investment in the penny stock category. The company has no debt and minimal short-term assets (CA$111.7K) compared to its liabilities (CA$3.4M), indicating liquidity challenges despite recent capital raises. It reported net losses for the third quarter and nine months ending July 31, 2024, highlighting ongoing financial struggles with increasing losses over five years at 38.2% annually. Its share price remains highly volatile, reflecting investor uncertainty amidst an unprofitable status and lack of experienced management data.

• Dive into the specifics of Captiva Verde Wellness here with our thorough balance sheet health report.
• Review our historical performance report to gain insights into Captiva Verde Wellness' track record.

Nano One Materials (TSX:NANO)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Nano One Materials Corp. produces and sells cathode active materials for lithium-ion batteries used in electric vehicles, energy storage systems, and consumer electronics, with a market cap of CA$85.74 million.

Operations: Nano One Materials Corp. has not reported any revenue segments.

Market Cap: CA$85.74M

Nano One Materials Corp., with a market cap of CA$85.74 million, is pre-revenue and focuses on cathode materials for lithium-ion batteries. Despite no debt and short-term assets (CA$14.7M) exceeding liabilities (CA$3.8M), the company faces challenges with less than a year of cash runway if current cash flow trends persist. Recent earnings show reduced losses, yet profitability remains elusive in the near term amidst high share price volatility. Strategic moves include expanding production capacity backed by a US$12.9 million grant to advance its technology licensing goals, supported by collaborations with global industry players like Sumitomo Metal Mining and Rio Tinto.

• Unlock comprehensive insights into our analysis of Nano One Materials stock in this financial health report.
• Gain insights into Nano One Materials' outlook and expected performance with our report on the company's earnings estimates.

California Nanotechnologies (TSXV:CNO)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: California Nanotechnologies Corp. focuses on the research, development, and production of nanocrystalline materials through grain size reduction, with a market cap of CA$47.54 million.

Operations: No specific revenue segments are reported for this company.

Market Cap: CA$47.54M

California Nanotechnologies Corp., with a market cap of CA$47.54 million, has transitioned from negative to positive shareholder equity, reflecting financial improvement. Despite recent earnings growth challenges and a net loss reported in the latest quarter, the company achieved US$3.27 million in sales over six months, marking significant revenue progress. The company recently expanded its manufacturing capabilities with a new facility in Santa Ana, enhancing its advanced material processing technologies and infrastructure. However, it faces high share price volatility and recent shareholder dilution as it navigates profitability hurdles while maintaining strong cash flow coverage for debt obligations.

• Click here and access our complete financial health analysis report to understand the dynamics of California Nanotechnologies.
• Evaluate California Nanotechnologies' historical performance by accessing our past performance report.

Turning Ideas Into Actions

• Jump into our full catalog of 959 TSX Penny Stocks here.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com